Semaglutide may support better hormone balance by: Improving insulin resistance (a major hormone disruptor) Reducing excess body fat Lowering inflammation For women with estrogen dominance related to weight, this can be a meaningful shift
Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials
Additional approaches include liposomal encapsulation, which mimics cell membrane structure to enhance cellular uptake, and emulsion-based systems that improve dispersion in water-based formulations
Understanding this difference helps alleviate the panic of thinking your reproductive system is permanently broken
If MASLD/NASH is a primary health concern alongside obesity, retatrutide could offer dual benefits that no current medication can match
Your follicles need growth signals, tissue repair, better blood flow, and a healthier environment